Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
  Interferon  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Transitional cell carcinoma in dogs - update in diagnosis and therapy
Transitional cell carcinoma (TCC) is the most common urinary tract tumor in dogs and research suggests that it may becoming more common. The main differential diagnosis and also the most common `misdiagnosis` is chronic recurrent cystitis. This excellent article gives an overview of the current diagnostic and therapeutic options.

Generally, TCC occurs in older dogs (mean age 11 years) and it occurs in females more frequently than in males.

The increasing incidence of TCC may be related to pet obesity, use of topical pesticides for fleas/ticks, or environmental pollutants. (Mutsaers AJ, Widmer WR, Knapp DW. Transitional Cell Carcinoma. J Vet Intern Med 2003: 136-144).

Diagnosis
Urinary tract tumors should be considered in any dog with hematuria, stranguria or polakyuria that does not rapidly and completely respond to appropriate antibiotic therapy.

Secondary urinary tract infections are common with TCC. The veterinarian should not exclude TCC from the rule-out list based on a positive urine culture or an improvement in clinical signs while on antibiotics.

The other rule-outs for recurring hematuria or dysuria include urinary calculi, resistant infections, anatomic defects, tumors other than TCC and rarely foreign bodies.

Initial evaluation for hematuria/dysuria should include: urinalysis, urine culture, rectal palpation to evaluate urethra/prostate and abdominal radiographs. Further evaluation might include CBC/chemistries, abdominal ultrasound, contrast studies, cystoscopy/vaginoscopy or surgery.

Urine screening test
A new urine screening test for transitional cell carcinoma is now also available (V-BTA test; Polymedco Inc; Redmond, Wash.) The test is a latex agglutination assay for glycoproteins released from the basement membrane of the bladder affected by cancer.

The test has a sensitivity of 90 percent and a specificity of 78 percent. Interference with the test (causing false positives) occurs with marked glucosuria (4+), heavy proteinuria (4+) or pyuria/hematuria (>30-40 WBC or RBC/hpf). Therefore a negative test has an accurate negative predictive value of 95 percent, but a positive test result would mean that further evaluation is indicated to rule-in or rule-out neoplasia.

Definitive diagnosis of TCC requires a histopathologic evaluation of tissue collected by catheter biopsy (usually ultrasound-guided), cystoscopy or cystotomy. Ultrasound also provides information regarding possible metastasis to lymph nodes or other organs, and provides information regarding possible surgical resection of the tumor.

If ultrasound is not available, or of limited usefulness due to tumor mineralization or distal uretheral involvement, contrast cystourethrogram is indicated.
TCC most commonly affects the trigone of the bladder and therefore curative surgical resection is often not possible due to ureter involvement. Therefore, understanding anatomic involvement prior to surgery is very useful for therapy and prognosis.

Therapy
1. Surgery: Whenever possible, surgical resection with margins is ideal, but this is usually limited to the situation of bladder apex tumors. Debulking of vaginal urethral tumors is sometimes necessary to maintain ability to urinate and relieve discomfort.

2. Chemotherapy: TCC is generally poorly responsive to chemotherapy. Although some response has been reported to doxorubricin/cyclophosphamide and doxorubricin/platinum combinations.

NSAID therapy with piroxicam has led to partial remissions as well as rare complete remissions. Unlike chemotherapy agents, piroxicam appears to cause apoptosis of TCC cells. Piroxicam is a strong NSAID and so may cause gastrointestinal irritation.

This author does not automatically use a histamine blocker or sucralfate concomitantly, but will if clinical signs of nausea, inappetance or melena warrant it. I never use prednisone concurrently with piroxicam due to the marked increase of gastrointestinal ulcers when using these drugs together.


Source: Lisa Ann Dzyban (2004): Recurring cystitis or something else? In: DVM Newsmagazine
June 1, 2004; www.dvmnewsmagazine.com/dvm/



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Anatomy of the canine tarsus in the MRImembers
This recently published prospective descriptive study on three canine cadavers was performed to describe the normal anatomy of the soft tissues of the canine tarsus as identified on computed tomography (CT) and magnetic resonance imaging (MRI) and to evaluate specific MRI sequences and planes for observing structures of diagnostic interest. Can the anatomy of this joint readilyy be identified via MRI?

  • Transepidermal water loss (TEWL) and severity of clinical signs (CADESI-03) in atopic dogsmembers
  • Two novel mutations associated with hemophilia A in different breedsmembers
  • Joint distractor to facilitate arthroscopy of the canine hip joint members
  • New tool for cancer immunotherapy in animalsmembers
  • Propofol versus ketofol in the induction of anaesthesia in healthy dogs
  • Alfaxalone or ketamine-medetomidine in cats undergoing ovariohysterectomy?
  • Elastography of liver, kidney and spleen of dogs members
  • Comparison of three ultrasound guided approaches to the lumbar plexus in dogs
  • Diffusion-weighted MRI of the normal dogs´s brainmembers
  • External radiation therapy of canine bladder cancermembers
  • Capsular tension ring use in canine phacoemulsification members
  • Symmetric Dimethylarginine Serum Concentration and Glomerular Filtration Rate in Catsmembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2013 VetContact GmbH
    All rights reserved